Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05632731

Comparison of Clinical Outcomes in Fresh Cycle With Single Blastocyst Stage and Double Cleavage-stage Embryos: a Single-center, Non-blind, Randomized Controlled Study

Conditions: Infertility, Female

Sex: Female
Ages: 18 Years – 38 Years
Phase: NA
Enrollment: 1236
Sponsor: Women's Hospital School Of Medicine Zhejiang University

Summary

In traditional assisted reproductive technology (ART), choosing multiple embryo transfer to get a high clinical pregnancy rate while increasing the risk of multiple pregnancies. Research showed that the single-cleavage embryo transfer could not simultaneously meet the dual requirements of maintaining pregnancy rate and reducing the multiple pregnancy rate.The purpose of this study was to observe the clinical outcome between double cleavage embryo transfers and single blastocyst transfers in fresh cycle through RCT study with GnRH antagonist protocol.

Eligibility Criteria

Inclusion Criteria:patients with a diagnosis of primary or secondary infertility with a clinical indication for IVF/intracytoplasmic sperm injection (ICSI)under 38 years of agenumber of AFC≥6, AMH>1.1ng/mlno adverse factors of fresh embryo transplantation (evaluation by an experienced reproductive physician)number of available embryos(day 3)≥4informed consentExclusion Criteria:PGTwith adenomyosis, endometrial compression by uterine fibroids, intrauterine adhesion, endometrial polyps and other factors unsuitable for fresh cycle transplantation

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05632731). StuddyBuddy aggregates publicly available trial information.